Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Cepharanthine could be a strong antiviral against COVID-19.

Five FDA-approved drugs may help block COVID-19 virus entry.

TRPV1 affects sebaceous gland function and could help treat acne.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

CaBP1 and CaBP2 are necessary for proper hearing and neurotransmission in the ear's inner hair cells.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

Pranlukast and mirabegron may work as new diabetes drugs.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Bicalutamide added no extra benefit over minoxidil alone for female-pattern hair loss.